Emerging Considerations in the Use of Immune Checkpoint Inhibitors: CRC
Drs Bendell and Lee discuss the role of checkpoint inhibition in the management of patients with colorectal cancer.
This activity is intended for oncologists, gastroenterologists, surgeons, nurses, and other healthcare professionals who treat patients with colorectal cancer.
The goal of this activity is to discuss advances in the use of immunotherapy to treat patients with colorectal cancer.
Approximate Time to Complete: 15 minutes
Course Available Beginning: Aug. 14, 2017
Developed through a partnership between SITC and Medscape.
 |
 |
- Have increased knowledge regarding the clinical trial data on the use of biomarkers to guide use of immune checkpoint inhibitors in the management of colorectal cancer (CRC)
- Have increased knowledge regarding the potential impact of recent clinical data on treatment strategies for patients with CRC